Roivant Sciences子公司Genevant将向Moderna授予传染病应用LNP递送技术非独家许可

美股速递
Mar 04

根据和解协议,Roivant Sciences Ltd.旗下子公司Genevant Sciences将向Moderna, Inc.授予一项非独家许可,允许其将脂质纳米颗粒递送技术用于传染病领域的应用。此项安排解决了双方之间存在的知识产权争议。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10